期刊
ORGANIC LETTERS
卷 23, 期 7, 页码 2443-2448出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.1c00329
关键词
-
资金
- National Natural Science Foundation of China [21772085, 21971107, 22071101]
- Fundamental Research Funds for the Central Universities [020514380220, 020514380131, 020514913412, 020514913214]
- Natural Science Foundation of Jiangsu Province [BK20200610]
- Postdoctoral Science Foundation of China [2019M661720]
- Jiangsu Provincial Key Laboratory of Photonic and Electronic Materials at Nanjing University
The asymmetric introduction of the CF3 unit can modify pharmacokinetic properties and slow metabolic degradation in medicinal chemistry. Computational studies show that the choice of ligand in a designed palladium-complex system regulates the regioselectivity and stereoselectivity of the asymmetric allylic alkylation of alpha-CF3 ketones and Morita-Baylis-Hillman adducts.
The asymmetric introduction of the CF3 unit is a powerful tool for modifying pharmacokinetic properties and slowing metabolic degradation in medicinal chemistry. A catalytic and enantioselective addition of alpha-CF3 enolates allows for expeditious access to functionalized chiral building blocks with CF3-containing stereogenicity. The computational studies reveal that the choice of ligand in a designed palladium-complex system regulates the regioselectivity and stereoselectivity of the asymmetric allylic alkyation of alpha-CF3 ketones and Morita-Baylis-Hillman adducts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据